- Analytical Testing
- Isoprenoids
- 极光® 金探针
- 脂肪酸修饰脂质
- Neutral Lipids
- Photoswitchable Lipids
- 佐剂
- 脂质试剂盒
- Polymers & Polymerizable Lipids
- Stable Isotopes & ESR Probes
- Lipopeptides
- Click Reagents
- Solvent Mixtures
- Cationic Lipids
- Bile Acids
- 辅酶A及其衍生物
- Avanti洗涤剂产品
- Sphingolipids
- Formulations
- Lipidomics
- Bacterial Lipids
870295 | DSPE-RGD
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-(cysarginylglycylaspartate-maleimidomethyl)cyclohexane-carboxamide] (sodium salt)

DSPE-RGD
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-(cysarginylglycylaspartate-maleimidomethyl)cyclohexane-carboxamide] (sodium salt)
RGD modified liposomes show potential for cancer research
- ChemDraw File
- 3D Structure
- Structure
- Safety Data Sheet
Chen CW, Lu DW, Yeh MK, Shiau CY, Chiang CH. Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells. Int J Nanomedicine. 2011;6:2567-80. doi: 10.2147/IJN.S24447. Epub 2011 Oct 26. PMID: 22128247; PMCID: PMC3225218.
PubMed ID: 22128247Cao Y, Zhou Y, Zhuang Q, Cui L, Xu X, Xu R, He X. Anti-tumor effect of RGD modified PTX loaded liposome on prostatic cancer. Int J Clin Exp Med. 2015 Aug 15;8(8):12182-91. PMID: 26550128; PMCID: PMC4612813.
PubMed ID: 26550128- Certificate of Analysis(Lot No. 870295P-1MG-A-010and 6184PGA010)
- Certificate of Analysis(Lot No. 870295P-1MG-B-010and 6184PGB010)
- Certificate of Analysis(Lot No. 870295P-1MG-C-010and 6184PGC010)
- Certificate of Analysis(Lot No. 870295P-1MG-D-010and 6184PGD010)
- Certificate of Analysis(Lot No. 870295P-1MG-A-011and 6184PGA011)
- Certificate of Analysis(Lot No. 870295P-1MG-B-011and 6184PGB011)
- Certificate of Analysis(Lot No. 870295P-1MG-D-011and 6184PGD011)


